Serum levels of selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: Case-control study

8Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Introduction: Mortality and morbidity related to traumatic brain injuries still remain high in patients. Many authors reported the importance of Selenium in maintaining the integrity of brain functions. This fact is supported by clinical evidence that therapy with selenium supplementation could help patients suffering from brain disorders like neurodegenerative diseases. The aim of our study was to assess the relationship between Selenium concentration in serum and evolution of comatose patients with severe traumatic brain injury, in the first week of admission, and the correlation between selenium and C-reactive protein. Methods: This case-control study was conducted with 64 comatose patients with TBI, in the Department of Anesthesiology and Reanimation, IbnSina University Hospital and Hospital of specialties in Rabat-Morocco, and healthy volunteers recruited in Blood transfusion center of Rabat. Blood sampling was collected from TBI patients, in the first week (3h after admission and each 48h during one week), and from healthy volunteers one time. Concentration of Se in serum was determined by electrochemical atomic absorption spectrometry. Statistical analysis was performed using Statistical software (SPSS) and the cases and controls were compared using the Mann-Whitney U test. A P-value < 0.05 was considered to be statistically significant. Results: Comparison selenium concentration in the first day (D0), third day (D2) and fifth day according to the death and survival statue in patients did not show statistical significance (p > 0.05). Selenium concentration of D0 in patients and Selenium concentration in control group also did not show statistical significance (p > 0.05). Similarly, we did not report a correlation between selenium and C-reactive protein. Conclusion: According to our data selenium and CRP may not play a role in progression of coma state in patients with severe traumatic brain injury.

References Powered by Scopus

Acute-phase proteins and other systemic responses to inflammation

5590Citations
N/AReaders
Get full text

Characterization of mammalian selenoproteomes

2021Citations
N/AReaders
Get full text

Selenium, selenoproteins and human health: A review

790Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Usefulness of serum interleukin-33 as a prognostic marker of severe traumatic brain injury

23Citations
N/AReaders
Get full text

Serum ST2 as a potential prognostic biomarker for traumatic brain injury

22Citations
N/AReaders
Get full text

Traumatic Brain Injury in Select Low-and Middle-Income Countries: A Narrative Review of the Literature

18Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Belatar, B., Laidi, F., El Abidi, A., Eljaoudi, R., Mamouch, F., Kabbaj, S., & Maazouzi, W. (2018). Serum levels of selenium and C-reactive protein in comatose patients with severe traumatic brain injury during the first week of hospitalization: Case-control study. Pan African Medical Journal, 29. https://doi.org/10.11604/pamj.2018.29.36.10945

Readers over time

‘18‘19‘20‘21‘22‘2302468

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 9

90%

Researcher 1

10%

Readers' Discipline

Tooltip

Medicine and Dentistry 6

43%

Nursing and Health Professions 4

29%

Biochemistry, Genetics and Molecular Bi... 2

14%

Psychology 2

14%

Save time finding and organizing research with Mendeley

Sign up for free
0